Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

The cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.

Vanda and AnaptysBio have announced an exclusive worldwide licence agreement to develop and commercialise imsidolimab to ...

On World Cancer Day, tackling barriers in equitable care requires not only policy action, but a shift in how cancer is ...

In a statement released on World Cancer Day (4 February), WHO’s Southeast Asia regional director Saima Wazed stated that the ...

USC has received a $6m grant from the California Institute for Regenerative Medicine (CIRM) to advance a new gene therapy for ...

EMA's CHMP has recommended AstraZeneca's Imfinzi for approval in the EU as a single agent for limited-stage small cell lung ...

Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

Microplastics, tiny plastic bits less than five millimetres in size, come from breaking down larger plastics and are now ...